IP Library Granted Patent US 8,192,474
Granted Patent B2
US 8,192,474 · App. 11/558,046 · Granted Jun 5, 2012

Tissue treatment methods

Assignee: Zeltiq Aesthetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,192,474
App. No.
11/558,046
Granted
Jun 5, 2012
Kind
B2
Abstract

Methods are provided herein for affecting a region of a subject's body, comprising exposing the region to a cooling element under conditions effective to cool subcutaneous adipose tissue in said region; and increasing the blood flow rate to the cooled tissue by exposing the tissue to an energy source. Methods are also provided for treating subcutaneous adipose tissue in a region of a subject's body, comprising exposing said region to a cooling element under conditions effective to cool said tissue; and exposing the tissue to an energy source to increase the blood flow rate to the cooled tissue, thereby stimulating reperfusion in, and/or causing an ischemia-reperfusion injury to, the cooled tissue.

Claims (40)

1. A method for selective reduction of lipid-rich cells in a region of a human subject's body, comprising:

treating the region to encourage formation of oxygen radicals by locally administering an oxygen radical forming compound;

exposing an epidermal layer in said region to a cooling element under conditions effective to cool subcutaneous adipose tissue in said region; and

increasing a rate of blood flow to the cooled tissue by exposing the region to an energy source.

2. The method of claim 1 , further comprising cycling at least one of the steps of exposing said region to a cooling element and increasing blood flow.

3. The method of claim 1 , further comprising the step of increasing vasoconstriction.

4. The method of claim 1 , wherein the energy source causes the blood flow rate to increase more rapidly than would occur without the energy source.

5. The method of claim 1 , wherein the cooling element is maintained at an average temperature between about −20° C. and about 5° C.

6. The method of claim 1 , wherein the epidermal layer in said region is exposed to the cooling element from about 2 min to about 60 min.

7. The method of claim 1 , wherein the cooling element includes a thermoelectric cooling element.

8. The method of claim 1 , wherein the cooling element includes a cooling agent circulating through the cooling element.

9. The method of claim 1 , wherein the energy source provides at least one of thermal, vibrational, acoustic, and electromagnetic energy.

10. The method of claim 1 , wherein the energy source provides mechanical energy.

11. The method of claim 1 , wherein the energy source is applied such that the region is warmed to at least about normal body temperature.

12. The method of claim 1 wherein the energy source is applied such that the region is warmed to a temperature warmer than the temperature of the cooled tissue.

13. The method of claim 12 wherein the region is warmed sufficient to stimulate reperfusion.

14. The method of claim 1 , wherein the energy is applied for from about 1 sec to about 30 min.

15. The method of claim 1 , wherein energy of about 10 J/cm2 to about 1000 J/cm2 is applied to the tissue.

16. The method of claim 1 , wherein the steps produce ischemia-reperfusion injury.

17. The method of claim 1 , further comprising treating the region to encourage formation of intracellular and/or extracellular ion concentrations at other than normal levels.

18. A method of treating subcutaneous adipose tissue in a region of a subject's body, comprising:

treating the region to encourage formation of oxygen radicals by locally administering an oxygen radical forming compound;

exposing said region to a cooling element under conditions effective to cool said tissue; and

stimulating reperfusion in the cooled tissue by exposing the region to an energy source to increase the blood flow rate to the cooled tissue.

19. The method of claim 18 , wherein stimulating reperfusion in the tissue causes ischemia-reperfusion injury to adipocytes in the tissue.

20. The method of claim 18 , wherein the energy source causes the blood flow rate to increase more rapidly than would occur without the energy source.

21. A method of treating subcutaneous adipose tissue in a region of a subject's body, comprising:

treating the region to encourage formation of oxygen radicals by locally administering an oxygen radical forming compound;

exposing said region to a cooling element under conditions effective to cool said tissue; and

causing an ischemia-reperfusion injury to the cooled tissue by exposing the region to an energy source to increase the blood flow rate to the cooled tissue.

22. A method for selective reduction of lipid-rich cells in a region of a human subject's body, comprising:

treating the region to encourage formation of oxygen radicals by locally administering an oxygen radical forming compound;

selectively causing vasoconstriction in adipose tissue; and

subsequently stimulating reperfusion by applying an energy source to thereby increase blood flow to the region.

23. The method of claim 22 wherein the step of causing vasoconstriction is by applying pressure.

24. The method of claim 22 wherein the step of causing vasoconstriction is by administration of drugs.

25. A method for selective reduction of lipid-rich cells in a region of a human subject's body, comprising:

treating the region to encourage formation of oxygen radicals by locally administering an oxygen radical forming compound;

selectively creating ischemia in lipid-rich cells in a region of a human subject's body; and

subsequently stimulating reperfusion by applying an energy source to thereby increase the blood flow.

Assignments (2)
CHANGE OF NAME Recorded Aug 22, 2007
From: JUNIPER MEDICAL, INC.
To: ZELTIQ AESTHETICS, INC.
Reel/Frame 019730/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2006
From: LEVINSON, MITCHELL
To: JUNIPER MEDICAL, INC.
Reel/Frame 018500/0847 →
Continuity (1)
Related Publication 20080077202A1 · Mar 27, 2008